Acute-phase bypass surgery for ruptured intracranial aneurysm: Selection criteria in the endovascular era

破裂性颅内动脉瘤急性期搭桥手术:血管内治疗时代的选择标准

阅读:5

Abstract

BACKGROUND: Although endovascular treatment (EVT) has become the predominant modality for intracranial aneurysms, a subset of ruptured aneurysms still requires bypass surgery in the acute phase. However, clear criteria for selecting candidates remain limited. This study aimed to evaluate the outcomes of acute-phase bypass surgery and to propose a pragmatic framework for treatment selection in the endovascular era. METHODS: Among 138 consecutive patients with aneurysmal subarachnoid hemorrhage treated between 2019 and 2024, we retrospectively analyzed 13 patients who underwent bypass surgery within 24 h of ictus. All cases were classified using a predefined three-step framework assessing (1) the need for parent artery trapping, (2) the presence of a branch arising from the aneurysm, and (3) the risk of parent artery compromise with direct clipping. Clinical characteristics, procedural details, bypass patency, complications, and functional outcomes were reviewed. RESULTS: Seven patients were categorized as Type I, three as Type II, and three as Type III. Intraoperative and postoperative imaging confirmed bypass patency in all cases. One patient developed a postoperative infarction following endovascular internal trapping, but no ischemic events attributable to bypass occlusion occurred. The median follow-up duration was 18 months, and at the last follow-up, 7 of 13 patients (54%) achieved favorable outcomes (modified Rankin Scale 0-2). CONCLUSION: Acute-phase bypass surgery, when guided by a structured framework, can be performed with high patency and acceptable outcomes in selected patients with ruptured aneurysms. This streamlined strategy may support consistent treatment selection and appropriate referral in the EVT era.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。